LL-37
Cathelicidin, hCAP-18, FALL-39, CAP-18
An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.
Suspended
NA
NCT04225819
Adjunctive Treatment With Vitamin D3 in Patients With Active IBD
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT00788138
Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis
Emory University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02945683
Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic Dermatitis
Noos S.r.l.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT06279910
Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).
Complejo Hospitalario Universitario de Albacete
OBSERVATIONAL
Updated Dec 15, 2025
Withdrawn
NA
NCT01858051
Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT01308619
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Galderma R&D
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01689779
High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT00938600
Antenatal Vitamin D3 Dose-finding and Safety Study
Johns Hopkins Bloomberg School of Public Health
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT01893385
Vitamin D Supplementation and the Immune Response
University Hospital, Clermont-Ferrand
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01702974
Immune Reconstitution in HIV Disease (IREHIV)
Karolinska Institutet
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT05431218
Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD
Karaganda Medical University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01689441
Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis
Brigham and Women's Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01798680
Trial of Vitamin D in HIV Progression
Harvard School of Public Health (HSPH)
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT04722640
Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity
Istituto Clinico Humanitas
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT04880824
Analysis of Frailty Syndrome Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)
Charite University, Berlin, Germany
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02278172
The Effects of Vitamin D Supplementation on Aerobic Fitness in Athletes
University of Ulster
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT04292548
Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children
Merve Erkmen Almaz
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NCT04404335
The Role of Anti-inflammatory Cytokines and Antimicrobial Peptide LL-37 Biomarkers in the Treatment of Periodontal Disease.
Universidad Rey Juan Carlos
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
NCT04858217
Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers
Istituto Ortopedico Rizzoli
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NCT00407979
Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis
National Institute of Allergy and Infectious Diseases (NIAID)
OBSERVATIONAL
Updated Dec 15, 2025